Devices, systems and methods for the broad-spectrum reduction of pro-inflammatory cytokines in blood
AssigneeSigyn Therapeutics, Inc.
InventorsCraig P. Roberts, James A. Joyce
Life of this patent
Estimating the term…
Loading patent…
AssigneeSigyn Therapeutics, Inc.
InventorsCraig P. Roberts, James A. Joyce
Estimating the term…
Devices, systems and methods for the broad-spectrum reduction of pro-inflammatory cytokines in blood. The pro-inflammatory cytokines can be freely circulating in the blood as well as cytokines that are transported within or bound to the surface of particles collectively referred to as CytoVesicles while simultaneously adsorbing toxins and pathogens from blood and blood plasma. A plasma separation column with binding, capture and adsorbent components optimize the removal of cytokines and CytoVesicles from blood while minimizing the removal of essential blood elements. Adsorbent components are incorporated within the extra-lumen space, outside of the plasma fiber walls and within the outer shell of the column and can include activated carbon, ion exchange resins and non-ionic exchange resins. The resulting devices, systems and methods alleviate the symptoms or severity of a wide range of disease conditions associated with an abnormal production or dysregulation of pro-inflammatory cytokines.
An extracorporeal system for the removal of inflammatory agents from blood, comprising:
A method for treating a disease or disorder in an individual in need thereof, comprising:
A method of simultaneously removing circulating cytokines, CytoVesicles, cytokine aggregates, and bacterial endotoxins from the blood of an individual in need thereof;
Dependencies are inferred from the claim text.